Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The more the share get acculated

I think that's a logical and actually a smart move by the infringers as I've posted before. I do have concerns as to whether there are regulations that would prevent this since the infringers have inside info regarding the status& of settlements

However, as long as settlements end up as purely cash deals, with no shares, warrants, or options as part of the deal, it seems like the companies should be able to do so to some extent, outside of some window of action on settlments I would think.

Share
New Message
Please login to post a reply